Key facts
- WALTERS GROUP filed SCHEDULE 13G/A for Zentalis Pharmaceuticals, Inc. Common Stock, $0.001 par value per share (ZNTL).
- Disclosed ownership: 20%.
- Date of event: 31 Dec 2025.
WALTERS GROUP - 31 Dec 2025 SCHEDULE 13G/A Report for Zentalis Pharmaceuticals, Inc. Common Stock, $0.001 par value per share (ZNTL)
- Filing Manager
- WALTERS GROUP
- Reporting Manager
- Walters William T
- Symbol
- ZNTL
- Shares outstanding
- 68,578,543 shares
- Disclosed Ownership
- 13,509,973 shares
- Ownership
- 20%
- Form type
- SCHEDULE 13G/A
- Filing time
- 05 Jan 2026, 20:40:02 UTC
- Date of event
- 31 Dec 2025
- SEC
- View on sec.gov
Key filing fact
WALTERS GROUP disclosed 20% ownership in Zentalis Pharmaceuticals, Inc. Common Stock, $0.001 par value per share (ZNTL) on 31 Dec 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 05 Jan 2026, 20:40.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (3)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Walters William T | 20% | 13,509,973 | 0 | 13,509,973 | /s/ William T. Walters | William T. Walters/Individual | |
| WALTERS GROUP | 20% | 13,509,973 | 0 | 13,509,973 | /s/ Susan B. Walters | Susan B. Walters/General Partner | |
| Walters, Susan B. | 20% | 13,509,973 | 0 | 13,509,973 | /s/ Susan B. Walters | Susan B. Walters/Individual |
CIK / CUSIP context first